首页> 外文期刊>The Journal of biological chemistry >Shedding of the Mer Tyrosine Kinase Receptor Is Mediated by ADAM17 Protein through a Pathway Involving Reactive Oxygen Species, Protein Kinase Cδ, and p38 Mitogen-activated Protein Kinase (MAPK)
【24h】

Shedding of the Mer Tyrosine Kinase Receptor Is Mediated by ADAM17 Protein through a Pathway Involving Reactive Oxygen Species, Protein Kinase Cδ, and p38 Mitogen-activated Protein Kinase (MAPK)

机译:MER酪氨酸激酶受体的脱落由ADAM17蛋白通过涉及反应性氧,蛋白激酶Cδ和P38丝裂型活化蛋白激酶(MAPK)的途径介导的途径

获取原文
           

摘要

Mer tyrosine kinase (MerTK) is an integral membrane protein that is preferentially expressed by phagocytic cells, where it promotes efferocytosis and inhibits inflammatory signaling. Proteolytic cleavage of MerTK at an unidentified site leads to shedding of its soluble ectodomain (soluble MER; sMER), which can inhibit thrombosis in mice and efferocytosis in vitro. Herein, we show that MerTK is cleaved at proline 485 in murine macrophages. Site-directed deletion of 6 amino acids spanning proline 485 rendered MerTK resistant to proteolysis and suppression of efferocytosis by cleavage-inducing stimuli. LPS is a known inducer of MerTK cleavage, and the intracellular signaling pathways required for this action are unknown. LPS/TLR4-mediated generation of sMER required disintegrin and metalloproteinase ADAM17 and was independent of Myd88, instead requiring TRIF adaptor signaling. LPS-induced cleavage was suppressed by deficiency of NADPH oxidase 2 (Nox2) and PKCδ. The addition of the antioxidant N-acetyl cysteine inhibited PKCδ, and silencing of PKCδ inhibited MAPK p38, which was also required. In a mouse model of endotoxemia, we discovered that LPS induced plasma sMER, and this was suppressed by Adam17 deficiency. Thus, a TRIF-mediated pattern recognition receptor signaling cascade requires NADPH oxidase to activate PKCδ and then p38, culminating in ADAM17-mediated proteolysis of MerTK. These findings link innate pattern recognition receptor signaling to proteolytic inactivation of MerTK and generation of sMER and uncover targets to test how MerTK cleavage affects efferocytosis efficiency and inflammation resolution in vivo.
机译:MER酪氨酸激酶(MERTK)是一种整体膜蛋白,优先由吞噬细胞表达,其中促进癫痫细胞毒性并抑制炎症信号传导。在身份不明的部位达到术的蛋白水解裂解导致其可溶性胞外肿瘤(可溶性MER; SMER)脱落,这可以抑制小鼠和体外效力症的血栓形成。在此,我们表明Mertk在鼠巨噬细胞的脯氨酸485处切割。通过切割诱导刺激诱导刺激诱导促进脯氨酸485的遍布脯氨酸485的6个氨基酸的定向缺失使抗肌肉溶性和抑制效率细胞增多。 LPS是已知的Mertk切割诱导剂,并且该动作所需的细胞内信号传导途径未知。 LPS / TLR4介导的SMER生成所需的Disintegrin和金属蛋白酶ADAM17,而是独立于MYD88,而是需要TRIF适配器信号传导。通过NADPH氧化酶2(NOX2)和PKCδ的缺乏抑制LPS诱导的裂解。添加抗氧化N-乙酰半胱氨酸抑制pKCδ,并且PKCδ的沉默抑制MAPK P38,也需要。在内毒素血症的小鼠模型中,我们发现LPS诱导的血浆SMER,这被ADAM17缺乏抑制。因此,TRIF介导的图案识别受体信号级联需要NADPH氧化酶以激活PKCδ,然后是P38,最终在Adam17介导的Mertk蛋白分解中。这些发现将先天图案识别受体信号链接到肌肉溶液的蛋白水解灭活和发射中的SMER和揭示靶标以测试MERTK切割如何影响体内癫痫菌效率和炎症分辨率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号